Search

everythinglearnresearchcommunity

for

Search:↓

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Statins may help treat alopecia areata by reducing harmful immune interactions.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

The enzyme pyruvate kinase M2 helps hair regrowth and could be a potential treatment for hair loss.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Hydroxytyrosol helps reduce liver injury by blocking certain inflammation pathways.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

Janus kinase inhibitors are effective and safe for treating alopecia areata.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

A woman's hair turned white after taking a cancer drug called dasatinib.

Tislelizumab can cause cutaneous lupus erythematosus.

Biological therapy boosts the immune system to effectively fight melanoma.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Finasteride may help reduce tic severity in male Tourette syndrome patients.

Tgm2 helps stabilize dying cells and aids fibroblast attachment to the extracellular matrix.

New therapies are being developed that target integrin pathways to treat various diseases.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.